In the last 12 months, insiders at Lipocine Inc. ($LPCN) filed 20 transactions with the SEC: 1 open-market purchases totaling $50,500 and 0 sales totaling $0. Net insider sentiment: net buying.
Lipocine Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Patel Mahesh V. (Chief Executive Officer) — 6 transactions totaling $50,527
- Papapetropoulos Spyros (Director) — 2 transactions totaling $10
- Higuchi John W. (Director) — 2 transactions totaling $10
- Jene Jill M. (Director) — 2 transactions totaling $10
- Ono Richard Dana (Director) — 2 transactions totaling $10
View all SEC Filings for Lipocine Inc. (LPCN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | Patel Mahesh V. | Chief Executive Officer | P | Common stock | 25000 | $2.02 | 135,679.0000 | 5,551,931 | 22.59% | 0.45% |
| Jan. 2, 2026 | Patel Mahesh V. | Chief Executive Officer | A | Stock Option (Right to Buy) | 25000 | $8.00 | 182,668.0000 | 5,551,931 | 15.86% | 0.45% |
| Dec. 18, 2025 | Fogarty Krista | Principal Accounting Officer | A | Stock Option (Right to Buy) | 20786 | $4.20 | 40,146.0000 | 5,551,931 | 107.37% | 0.37% |
| Dec. 18, 2025 | Patel Mahesh V. | Chief Executive Officer | A | Stock Option (Right to Buy) | 8629 | $4.20 | 157,668.0000 | 5,551,931 | 5.79% | 0.16% |
| June 4, 2025 | Higuchi John W. | Director | A | Common Stock (Right to Buy) | 1764 | $3.20 | 11,526.0000 | 5,350,356 | 18.07% | 0.03% |
| June 4, 2025 | Ono Richard Dana | Director | A | Common Stock (Right to Buy) | 1764 | $3.20 | 11,526.0000 | 5,350,356 | 18.07% | 0.03% |
| June 4, 2025 | Jene Jill M. | Director | A | Stock Option (Right to Buy) | 1764 | $3.20 | 7,174.0000 | 5,350,356 | 32.61% | 0.03% |
| June 4, 2025 | Papapetropoulos Spyros | Director | A | Stock Option (Right to Buy) | 1764 | $3.20 | 7,174.0000 | 5,350,356 | 32.61% | 0.03% |
| June 4, 2025 | Fink Jeffrey Arvin | Director | A | Common Stock (Right to Buy) | 1764 | $3.20 | 11,526.0000 | 5,350,356 | 18.07% | 0.03% |
| Jan. 2, 2025 | Patel Mahesh V. | Chief Executive Officer | A | Stock Option (Right to Buy) | 16371 | $4.86 | 149,039.0000 | 0 | 12.34% | 0.00% |
| Dec. 23, 2024 | Patel Mahesh V. | Chief Executive Officer | A | Stock Option (Right to Buy) | 10320 | $4.80 | 132,688.0000 | 0 | 8.43% | 0.00% |
| Dec. 23, 2024 | Fogarty Krista | Principal Accounting Officer | A | Stock Option (Right to Buy) | 5943 | $4.80 | 19,460.0000 | 0 | 43.97% | 0.00% |
| Dec. 23, 2024 | Patel Mahesh V. | Chief Executive Officer | A | Stock Option (Right to Buy) | 26691 | $4.80 | 149,039.0000 | 0 | 21.82% | 0.00% |
| June 5, 2024 | Ono Richard Dana | Director | A | Common Stock (Right to Buy) | 1764 | $7.05 | 10,938.0000 | 0 | 19.23% | 0.00% |
| June 5, 2024 | Papapetropoulos Spyros | Director | A | Stock Option (Right to Buy) | 1764 | $7.05 | 5,410.0000 | 0 | 48.38% | 0.00% |
| June 5, 2024 | Higuchi John W. | Director | A | Common Stock (Right to Buy) | 1764 | $7.05 | 10,938.0000 | 0 | 19.23% | 0.00% |
| June 5, 2024 | Jene Jill M. | Director | A | Stock Option (Right to Buy) | 1764 | $7.05 | 5,410.0000 | 0 | 48.38% | 0.00% |
| June 5, 2024 | Fink Jeffrey Arvin | Director | A | Common Stock (Right to Buy) | 1764 | $7.05 | 10,938.0000 | 0 | 19.23% | 0.00% |
| March 8, 2024 | Patel Mahesh V. | CEO and President | A | Common Stock | 4893 | $0.00 | 112,311.0000 | 0 | 4.56% | 0.00% |
| March 8, 2024 | Fogarty Krista | Principal Accounting Officer | A | Common Stock | 991 | $0.00 | 1,727.0000 | 0 | 134.65% | 0.00% |